Technical Analysis – USDCHF looks incapable of overstepping key resistance



USDCHF is currently tackling a durable resistance barrier around the 0.9030 mark, which is reinforced by the overlapping downtrend line, pulled from the 0.9472 high, the blue Kijun-sen line and the 50-period simple moving average (SMA). The former happens to be the 61.8% Fibonacci retracement of the up leg from 0.8757 until the nine-month peak of 0.9472. The bearish SMAs are shielding the downtrend, while the flattened Ichimoku lines are suggesting negative momentum may soon resume.

The short-term oscillators are signalling that current positive sentiment is feeble. The MACD is slowly improving in negative territory above its red trigger line. That said the RSI is struggling to step over the 50 level, while the stochastic %K line is stalling ahead of the 80 overbought threshiold.

If the multiple resistance obstacles around 0.9030 fail to discourage buyers, the price may catapult towards the 100-period SMA in the vicinity of the Ichimoku cloud’s upper band at 0.9074. Overcoming this, buyers may then challenge the 0.9093 and 0.9118 borders respectively, as the price aims for the 200-period SMA at 0.9150.

Should the falling trend line direct the price back down, initial friction could be met at the red Tenkan-sen line at 0.8993, before sellers face the support section of 0.8948-0.8967. Successfully slipping past this, the pair may rest at the 76.4% Fibo of 0.8926. Next, should negative pressures intensify, the price may sink towards the 0.8870 support level.

In conclusion, USDCHF is maintaining a sturdy bearish demeanour below the SMAs and the Ichimoku cloud.

Latest News


Technical Analysis – Gold fails to leave 1,800 level in the dust; upside shaky


Technical Analysis – EURUSD flirts with 1.1665 again bound by short-term SMAs



Technical Analysis – USDCAD retraces to 1.23 level before foothold takes shape

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.